Partnering & Outsourcing Editorial
-
Hidden Compliance Risks In Start-Up That Could Derail Your Clinical Trial
6/13/2025
Kulkarni Law Firm Senior Attorney Edye T. Edens explores the risks embedded in clinical trial start-up activities, such as site activation, contract execution, delegation of responsibilities, and cross-border data flows.
-
U.S. Tariffs And Their Tenuous Impact On Clinical Trials
6/10/2025
RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.
-
When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover
6/6/2025
Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.
-
Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action
5/20/2025
Celebrate Clinical Trials Day 2025 with these industry experts as they share experiences and advice related to trial design, regulatory and compliance, and outsourcing challenges.
-
Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources
5/20/2025
Celebrate Clinical Trials Day 2025 with these industry experts, who share their experiences in and advice for establishing partnerships and finding the best talent.
-
How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two
5/19/2025
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.
-
Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One
5/19/2025
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards.
-
3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization
5/13/2025
CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.
-
The Potential Impact Of U.S. Tariffs On The Biotech Sector: Manufacturing, Funding, And Clinical Trials
5/12/2025
Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.
-
When To Outsource — And How To Pick The Perfect Clinical Trial Partners
5/9/2025
EMED Technologies Director of Clinical Affairs Alex Nikanorov shares the company’s approach to deciding which clinical research functions to outsource and finding vendor partners that align with the company’s goals.